WEE1 and acute myeloid leukemia: WEE1 was identified to offer cytarabine-resistance in AML by two independent studies published in 2012, one utilized a genome-wide shRNA library [117] and the other one used a kinase-focused shRNA library (targeting 572 kinases) [30].